期刊文献+

美罗培南与哌拉西林舒巴坦在治疗慢性阻塞性肺病急性发作中的临床对比分析 被引量:4

The influence of meropenem and piperacillin/sulbactam in treatment of acute exacerbation of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的观察美罗培南与哌拉西林舒巴坦在治疗慢性阻塞性肺病急性发作时的疗效对比及副反应。方法对168例慢性阻塞性肺病急性发作患者随机分为两组,对其细菌情况及临床情况进行分析,幷对治疗情况进行对比?峁?两组均有较高的有效率,但在治疗时间及副作用上有一定差别。结论对不同的抗生素除应了解其身性能特点外,还应尽可能总结其临床应用特点,而不应该片面追求所谓高档抗生素。 Objective To observe the efficacy and side effects of meropenem and piperacillin/sulbactam on patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods 168 patients with AECOPD were divided into two groups randomly,and analysis the clinical features and results of laboratory tests.And to contrast the treatments of both.Results The two groups both had the high efficiency,but there are differences on time of treatment and side effects.Conclusion The clinical characteristics of different types of antibiotic is the foundation to select different application.
出处 《中国实用医药》 2012年第36期6-8,共3页 China Practical Medicine
关键词 美罗培南 哌拉西林舒巴坦 慢性阻塞性肺病急性发作 Meropenem Piperacillin/sulbactam AECOPD
  • 相关文献

参考文献17

  • 1Sethi S. New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease[J].Current Opinion in Infectious Diseases,2004.113-119.
  • 2Committee for the Japanese Respiratory Society guidelines for the management of respiratory infection. Guidelines for the management of community acquired pneumonia in adults,revised edition[J].Respirolory,2006,(supp 13):79-133.
  • 3王水利,罗小峰,赵岚,吴桦,孙钢,韩雪芳.12年来呼吸道感染病原菌回顾调查[J].中华医院感染学杂志,2006,16(7):828-830. 被引量:18
  • 4刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 6Gross NJ. chronic obstructive pulmonary disease; an evidence-based approach to treatment with a focus anticholinergic bronchodilation[J].Mayo Clinic Proceedings,2008,(11):1241-1245.
  • 7Larsen Mv,Janner JH,Nielson SD. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital[J].Scandinavian Journal of Infectious Diseases,2009,(01):26-32.
  • 8陈固萍,胡又专.慢性阻塞性肺疾病急性发作期患者病原菌分布与耐药分析[J].中国感染控制杂志,2007,6(5):338-341. 被引量:7
  • 9肖丹丹;肖发怀.慢性阻塞性肺病肺部真菌感染46例临床分析[J]中外健康文摘,2010(01):120-121.
  • 10Creer ND. Voriconazole,the newest triazole antifungal agent[J].Proc Bayl Univ Med cent,2003,(05):241-248.

二级参考文献51

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 5Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 6Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 7Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 8中华人民共和国卫生部.医院感染诊断标准(试行).(2001年1月2日颁布).南京:东南大学出版社,2001.
  • 9Clinical and Laboratory Standards Institute CLSI. 2006. Performance standards for antimicrobial susceptibility testing [ S ]. sixteenth informational supplement. Wayne, Pa.
  • 10Nseir S, Di Pompeo C, Cavestri B, et al. Multiple diaig-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med ,2006 ,34 : 2959-2966.

共引文献9067

同被引文献41

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部